The effective concentration of a drug in the blood, i.e. the concentration of a free drug in the blood, is influenced by the strength of drug binding onto plasma proteins. Besides its efficacy, these interactions subsequently influence the liberation, absorption, distribution, metabolism, excretion, and toxicological properties of the drug. It is important to not only determine the binding strength and stoichiometry, but also the binding site of a drug on the plasma protein molecule, because the co-administration of drugs with the same binding site can affect the above-mentioned concentration and as a result the pharmacological behavior of the drugs and lead to side effects caused by the change in free drug concentration, its toxicity. In this study, the binding characteristics of six drugs with human serum albumin, the most abundant protein in human plasma, were determined by capillary electrophoresis-frontal analysis, and the obtained values of binding parameters were compared with the literature data. The effect of several drugs and site markers on the binding of l-tryptophan and lidocaine to human serum albumin was investigated in subsequent displacement studies which thus demonstrated the usability of capillary electrophoresis as an automated high-throughput screening method for drug-protein binding studies.

Department of Biochemistry Faculty of Science Masaryk University Brno Czech Republic

Zobrazit více v PubMed

Zhou, D., Li, F. Tudy on drug displacement interactions by capillary electrophoresis-frontal analysis. Front. Chem. China 2006, 2, 207-210.

Yamasaki, K., Chuang, V. T. G., Maruyama, T., Otagiri, M. Albumin-drug interaction and its clinical implication. Biochim Biophys Acta-Gen Subj. 2013, 1830, 5435-43.

Nevidalova, H., Michalcova, L., Glatz, Z. In-depth insight into the methods of plasma protein-drug interaction studies: comparison of capillary electrophoresis-frontal analysis, isothermal titration calorimetry, circular dichroism and equilibrium dialysis. Electrophoresis. 2018, 39, 581-9.

Bteich, M. An overview of albumin and alpha-1-acid glycoprotein main characteristics: highlighting the roles of amino acids in binding kinetics and molecular interactions. Heliyon. 2019, 5, 1-8.

Colmenarejo, G. In silico prediction of drug-binding strengths to human serum albumin. Med Res Rev. 2003, 23, 275-301.

Bertucci, C., Domenici, E. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr Med Chem. 2002, 9, 1463-81.

Ghuman, J., Zunszain, P. A., Petitpas, I., Bhattacharya, A. A., Otagiri, M., Curry, S. Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol. 2005, 353, 38-52.

Abboud, R., Charcosset, C., Greige-Gerges, H. Interaction of triterpenoids with human serum albumin: a review. Chem Phys Lipids. 2017, 207, 260-70.

Sochacka, J., Baran, W. The investigation of the binding of 6-mercaptopurine to site I on human serum albumin. Protein J. 2012, 31, 689-702.

Khodaei, A., Bolandnazar, S., Valizadeh, H., Hasani, L., Zakeri-Milani, P. Interactions between sirolimus and anti-inflammatory drugs: competitive binding for human serum albumin. Adv Pharm Bull. 2016, 6, 227-33.

Rahman, M. M., Rahman, M. H., Rahman, N. N. Competitive binding of ibuprofen and naproxen to bovine serum albumin: modified form of drug-drug displacement interaction at the binding site. Pak J Pharm Sci. 2005, 18, 43-7.

Bhattacharya, A. A., Curry, S., Franks, N. P. Binding of the general anesthetics propofol and halothane to human serum albumin - High resolution crystal structures. J Biol Chem. 2000, 275, 38731-8.

Yamasaki, K., Rahman, M. H., Tsutsumi, Y., Maruyama, T., Ahmed, S., Kragh-Hansen, U., Otagiri, M. Circular dichroism simulation shows a site-II-to-site-I displacement of human serum albumin-bound diclofenac by ibuprofen. AAPS PharmSciTech. 2000, 1, 45-54.

Tayyab, S., Izzudin, M. M., Kabir, M. Z., Feroz, S. R., Tee, W.-V., Mohamad, S. B., Alias, Z. Binding of an anticancer drug, axitinib to human serum albumin: fluorescence quenching and molecular docking study. J Photochem Photobiol B-Biol. 2016, 162, 386-94.

Wybranowski, T., Ziomkowska, B., Cwynar, A., Kruszewski, S. The influence of displacement compounds on the binding of ochratoxin A to human serum albumin examined with fluorescence anisotropy methods. Opt Appl. 2014, 44, 357-64.

Zhang, X.-P., Hou, Y.-H., Wang, L., Zhang, Y.-Z., Liu, Y. Exploring the mechanism of interaction between sulindac and human serum albumin: spectroscopic and molecular modeling methods. J Lumines. 2013, 138, 8-14.

Hage, D. S. High-performance affinity chromatography: a powerful tool for studying serum protein binding. J Chromatogr B. 2002, 768, 3-30.

Li, Z.-M., Wei, C.-W., Zhang, Y., Wang, D.-S., Liu, Y.-N. Investigation of competitive binding of ibuprofen and salicylic acid with serum albumin by affinity capillary electrophoresis. J Chromatogr B. 2011, 879, 1934-8.

Erim, F. B., Kraak, J. C. Vacancy affinity capillary electrophoresis to study competitive protein-drug binding. J Chromatogr B. 1998, 710, 205-10.

Nilsson, M., Johansson, G., Isaksson, R. Determination of dissociation constants by competitive binding in partial filling capillary electrophoresis. Electrophoresis. 2004, 25, 1022-7.

Sowell, J., Mason, J. C., Strekowski, L., Patonay, G. Binding constant determination of drugs toward subdomain IIIA of human serum albumin by near-infrared dye-displacement capillary electrophoresis. Electrophoresis. 2001, 22, 2512-7.

Ding, Y. S., Zhu, X. F., Lin, B. C. Study of interaction between drug enantiomers and serum albumin by capillary electrophoresis. Electrophoresis. 1999, 20, 1890-4.

Fung, Y. S., Sun, D. X., Yeung, C. Y. Capillary electrophoresis for determination of free and albumin-bound bilirubin and the investigation of drug interaction with bilirubin-bound albumin. Electrophoresis. 2000, 21, 403-10.

Knjazeva, T., Kaljurand, M. Capillary electrophoresis frontal analysis for the study of flavonoid interactions with human serum albumin. Anal Bioanal Chem. 2010, 397, 2211-9.

Liu, X. M., Li, S. Y., Zhang, J. S., Chen, X. G. Flow injection-capillary electrophoresis frontal analysis method for the study of the interactions of a series of drugs with human serum albumin. J Chromatogr B. 2009, 877, 3144-50.

Liu, T. T., Xiang, L. L., Wang, J. L., Chen, D. Y. Application of capillary electrophoresis-frontal analysis for comparative evaluation of the binding interaction of captopril with human serum albumin in the absence and presence of hydrochlorothiazide. J Pharm Biomed Anal. 2015, 115, 31-5.

Ostergaard, J., Schou, C., Larsen, C., Heegaard, N. H. H. Evalution of capillary electrophoresis-frontal analysis for the study of low molecular weight drug-human serum albumin interactions. Electrophoresis. 2002, 23, 2842-53.

Sun, H. W., He, P. Characterization of interaction between doxycycline and human serum albumin by capillary electrophoresis-frontal analysis. Electrophoresis. 2009, 30, 1991-7.

Zhao, L. J., Chen, D. Y. Characterization of interactions between methoxatin disodium salt and human serum albumin by pressure-assisted capillary electrophoresis/frontal analysis and circular dichroism spectroscopy. Biomed Chromatogr. 2015, 29, 123-8.

Stepanova, S., Kasicka, V. Capillary electrophoretic methods applied to the investigation of peptide complexes. J Sep Sci. 2015, 38, 2708-21.

Michalcova, L., Glatz, Z. Comparison of various capillary electrophoretic approaches for the study of drug-protein interaction with emphasis on minimal consumption of protein sample and possibility of automation. J Sep Sci. 2015, 38, 325-31.

Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., Ascenzi, P. Human serum albumin: from bench to bedside. Mol Asp Med. 2012, 33, 209-90.

Petitpas, I., Bhattacharya, A. A., Twine, S., East, M., Curry, S. Crystal structure analysis of warfarin binding to human serum albumin - Anatomy of drug site I. J Biol Chem. 2001, 276, 22804-9.

Vuignier, K., Schappler, J., Veuthey, J. L., Carrupt, P. A., Martel, S. Improvement of a capillary electrophoresis/frontal analysis (CE/FA) method for determining binding constants: discussion on relevant parameters. J Pharm Biomed Anal. 2010, 53, 1288-97.

Ostergaard, J., Heegaard, N. H. H. Capillary electrophoresis frontal analysis: principles and applications for the study of drug-plasma protein binding. Electrophoresis. 2003, 24, 2903-13.

Kragh-Hansen, U. Relations between high-affinity binding-sites for L-tryptophan, diazepam, salicylate and phenol red on human-serum albumin. Biochem J. 1983, 209, 135-42.

Kragh-Hansen, U., Chuang, V. T. G., Otagiri, M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull. 2002, 25, 695-704.

Kratochwil, N. A., Huber, W., Muller, F., Kansy, M., Gerber, P. R. Predicting plasma protein binding of drugs: a new approach. Biochem Pharmacol. 2002, 64, 1355-74.

Hein, K. L., Kragh-Hansen, U., Morth, J. P., Jeppesen, M. D., Otzen, D., Moller, J. V., Nissen, P. Crystallographic analysis reveals a unique lidocaine binding site on human serum albumin. J Struct Biol. 2010, 171, 353-60.

Er, J. C., Vendrell, M., Tang, M. K., Zhai, D. T., Chang, Y. T. Fluorescent dye cocktail for multiplex drug-site mapping on human serum albumin. ACS Comb Sci. 2013, 15, 452-7.

Hossain, M. K., Khatun, A., Rahman, M., Akter, M. N., Chowdhury, S. A., Alam, S. M. M. Characterization of the effect of drug-drug interaction on protein binding in concurrent administration of sulfamethoxazol and diclofenac sodium using bovine serum albumin. Adv Pharm Bull. 2016, 6, 589-95.

di Masi, A., Gullotta, F., Bolli, A., Fanali, G., Fasano, M., Ascenzi, P. Ibuprofen binding to secondary sites allosterically modulates the spectroscopic and catalytic properties of human serum heme-albumin. FEBS J. 2011, 278, 654-62.

Dantas, D. S., Oliveira, J. I. N., Neto, J. X. L., da Cost, R. F., Bezerra, E. M., Freire, V. N., Caetano, E. W. S., Fulco, U. L., Albuquerque, E. L. Quantum molecular modelling of ibuprofen bound to human serum albumin. RSC Adv. 2015, 5, 49439-50.

Varshney, A., Sen, P., Ahmad, E., Rehan, M., Subbarao, N., Khan, R. H. Ligand binding strategies of human serum albumin: how can the cargo be utilized? Chirality. 2010, 22, 77-87.

Tao, P. Y., Li, Z., Matsuda, R., Hage, D. S. Chromatographic studies of chlorpropamide interactions with normal and glycated human serum albumin based on affinity microcolumns. J Chromatogr B. 2018, 1097, 64-73.

Awasthi, S., Murugan, N. A., Saraswathi, N. T. Advanced glycation end products modulate structure and drug binding properties of albumin. Mol Pharm. 2015, 12, 3312-22.

Joseph, K. S., Hage, D. S. Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography. J Chromatogr B. 2010, 878, 1590-8.

Aylward, M., Maddock, J. Plasma L-tryptophan concentrations in chronic rheumatic diseases and effects of some antirheumatic drugs on binding of amino-acid to plasma proteins in-vivo and in-vitro. Rheumatol Rehabil. 1974, 13, 62-74.

Bruderlein, H., Bernstein, J. Investigation of the L-tryptophan binding-site on serum-albumin, using cyclic analogs and fluorescent-probes. J Biol Chem. 1979, 254, 1570-6.

Zhang, Y., Lee, P., Liang, S. C., Zhou, Z. P., Wu, X. Y., Yang, F., Liang, H. Structural basis of non-steroidal anti-inflammatory drug diclofenac binding to human serum albumin. Chem Biol Drug Des. 2015, 86, 1178-84.

Bou-Abdallah, F., Sprague, S. E., Smith, B. M., Giffune, T. R. Binding thermodynamics of Diclofenac and Naproxen with human and bovine serum albumins: a calorimetric and spectroscopic study. J Chem Thermodyn. 2016, 103, 299-309.

Watzig, H., Oltmann-Norden, I., Steinicke, F., Alhazmi, H. A., Nachbar, M., Abd El-Hady,, D., Albishri, H. M., Baumann, K., Exner, T., Bockler, F. M., El Deeb, S. Data quality in drug discovery: the role of analytical performance in ligand binding assays. J Comput-Aided Mol Des. 2015, 29, 847-65.